WHY ARREST A FAILING HEART?
With more than 800,000+ CABG procedures globally each year, your opportunity to perform beating heart
surgery isn’t going away, it’s increasing.1 As patient populations expand, you’re
faced with treating sicker coronary patients who require complex therapies.
Find the right procedure, for the right patient.
Looking for improved outcomes? Consider Pump-Assist Beating Heart (PABH) as an option for your coronary patients. PABH includes the use of cardiopulmonary bypass, without arresting the patient’s heart or cross clamping the aorta. Read below to learn about the many benefits of PABH.
PABH OFFERS MANY CLINICAL BENEFITS
Cardiac surgeons are discovering that PABH offers better outcomes with specific patients. Data from several clinical studies support these improved outcomes.
THERAPY IDEAS AND SOLUTIONS FOR YOU
Find out how beating heart therapies can work with a technology solution from Medtronic. Together — with your skilled knowledge and our enabling technologies — we can deliver the right therapies for each individual patient with coronary artery disease (CAD).
Visit Cardiovascular Products
MICS CABG can reduce length of hospital stays and recovery times even further than traditional on-pump or off-pump CABG.5,6
LEARN MORE
OPCAB is associated with many clinical benefits.7-9
Discover the experience of Prof. Paul Sergeant, M.D.
IS YOUR HEART TEAM FAMILIAR WITH HCR?
Hybrid Coronary Revascularization combines MICS CABG and PCI. Colleagues at the London Health Sciences Centre share their experience about the procedure here.
VIEW HCR VIDEO AND PROCEDURE GUIDE
References
1
BCC Research, Cardiovascular Devices: Markets to 2022; Report code HLC210A, January 2018, page 28.
2
Erkut B, Dag O, Kaygin MA, et al. On-pump beating-heart versus conventional coronary artery bypass grafting for revascularization in patients with severe left ventricular dysfunction: early outcomes. Can J Surg. December 2013;56(6):398-404.
3
Afrasiabirad A, Safale N, Montazergaem H. On-pump beating coronary artery bypass in high risk coronary patients. Iran J Med Sci. January 2015;40(1):40-44.
4
Chaudhry UA, Harling L, Sepehripour AH, et al. Beating-heart versus conventional on-pump coronary artery bypass grafting: A meta-analysis of clinical outcomes. Ann Thorac Surg. December 2015;100(6):2251-2260.
5
Lapierre H, Chan V, Sohmer B, Mesana TG, Ruel M. Minimally invasive coronary artery bypass grafting via a small thoracotomy versus off-pump: a casematched study. Eur J Cardiothorac Surg. October 2011;40(4):804-810.
6
Cheng DC, Bainbridge D, Martin JE, et al. Does off-pump coronary artery bypass reduce mortality, morbidity, and resource utilization when compared with conventional coronary artery bypass? A meta-analysis of randomized trials. Anesthesiology. January 2005;102(1):188-203.
7
Puskas J, Cheng D, Knight J, et al. Off-pump versus conventional coronary artery bypass grafting: a meta-analysis and consensus statement from the 2004 ISMICS Consensus Conference. Innovations (Phila). Fall 2005;1(1):3-27.
8
Puskas J, Thourani V, Kilgo P, et al. Off-pump coronary artery bypass disproportionately benefits high-risk patients. Ann Thorac Surg. October 2009;88(4):1142-1147.
9
Mack MJ, Brown P, Houser F, et al. On-pump versus off-pump coronary artery bypass surgery in a matched sample outcome of women. A comparison of outcomes. Circulation. September 14, 2004;110(Suppl 1):II:1-6.
IMPORTANT SAFETY INFORMATION
Not all patients are candidates for beating heart procedures. Some patients would require cardiopulmonary support during surgery. Caution: Federal law (USA) restricts this device to sale by or on the order of a physician. For a listing of indications, contraindications, precautions and warnings, please refer to the Instructions for Use.
All rights reserved. Medtronic, Medtronic logo and Further, Together are trademarks of Medtronic. All other brands are trademarks of a Medtronic company.